Molecular and cellular functions of CTLA-4

S Van Coillie, B Wiernicki, J Xu - Regulation of Cancer Immune …, 2020 - Springer
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an inhibitory receptor belonging to
the CD28 immunoglobulin subfamily, expressed primarily by T-cells. Its ligands, CD80 and …

Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders

A Stray-Pedersen, HS Sorte, P Samarakoon… - Journal of Allergy and …, 2017 - Elsevier
Background Primary immunodeficiency diseases (PIDDs) are clinically and genetically
heterogeneous disorders thus far associated with mutations in more than 300 genes. The …

[HTML][HTML] A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells

HS Wong, K Park, A Gola, AP Baptista, CH Miller… - Cell, 2021 - cell.com
A fraction of mature T cells can be activated by peripheral self-antigens, potentially eliciting
host autoimmunity. We investigated homeostatic control of self-activated T cells within …

Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights

A Faje - Pituitary, 2016 - Springer
Introduction Advances in immunotherapy have transformed the management of metastatic
melanoma and generated encouraging results in the treatment of other malignancies …

Current genetic landscape in common variable immune deficiency

H Abolhassani, L Hammarström… - Blood, The Journal …, 2020 - ashpublications.org
Using whole-exome sequencing to examine the genetic causes of immune deficiency in 235
common variable immunodeficiency (CVID) patients seen in the United States (Mount Sinai …

Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review

A Fabre, S Marchal, V Barlogis, B Mari, P Barbry… - The Journal of Allergy …, 2019 - Elsevier
Background Signal transducer and activator of transcription 3 (STAT3) gain-of-function
(GOF) germline mutations have been recently described. A comprehensive overview of this …

[HTML][HTML] Development of immune checkpoint therapy for cancer

JM Fritz, MJ Lenardo - Journal of Experimental Medicine, 2019 - rupress.org
Since the early 20th century, immunologists have investigated mechanisms that protect
vertebrates from damaging immune responses against self-antigens by mature lymphocytes …

The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency

L Gámez-Díaz, D August, P Stepensky… - Journal of Allergy and …, 2016 - Elsevier
Background LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary
immunodeficiency caused by biallelic mutations in LRBA that abolish LRBA protein …

Therapeutic options for CTLA-4 insufficiency

D Egg, IC Rump, N Mitsuiki, J Rojas-Restrepo… - Journal of Allergy and …, 2022 - Elsevier
Background Heterozygous germline mutations in cytotoxic T lymphocyte–associated antigen-
4 (CTLA4) impair the immunomodulatory function of regulatory T cells. Affected individuals …

Treg cells in autoimmunity: from identification to Treg-based therapies

L Göschl, C Scheinecker, M Bonelli - Seminars in immunopathology, 2019 - Springer
Regulatory (Treg) cells are key regulators of inflammation and important for immune
tolerance and homeostasis. A major progress has been made in the identification and …